![Erik Esveld](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Esveld
Directeur Financier/CFO chez
Van Herk Investments BV
Profil
Erik Esveld currently works at Van Herk Groep BV, as Finance Director, Van Herk Investments BV, as Chief Financial Officer from 2012, Agendia NV, as Member-Supervisory Board from 2016, Agendia, Inc., as Member-Supervisory Board, and SkylineDx BV, as Member-Supervisory Board.
Mr. Esveld also formerly worked at Mendus AB, as Director, AEC Skyline Holding BV, as Director, Stichting Op Klompen Begonnen, as Director, Stichting Start2Cure, as Director, de Hoben GmbH, as Director, Campus Fraxinus Excelsior BV, as Director, Ht Projecktentwicklung GmbH, as Director, and BioInvent International AB, as Independent Director.
Mr. Esveld received his graduate degree in 2020 from Nyenrode Business Universiteit and undergraduate degree in 1994 from Erasmus University Rotterdam.
Postes actifs de Erik Esveld
| Sociétés | Poste | Début |
|---|---|---|
Van Herk Investments BV
 Van Herk Investments BV Investment ManagersFinance Van Herk Investments invests in companies located in Central and Eastern Europe, India and the United States, primarily in Europe with an enterprise value ranging from EUR 10 - 150 million. The firm focuses on a broad range of sectors and industries. It provides financing for early and buyout transactions. It also makes investments public companies and venture capital funds. | Directeur Financier/CFO | 20/12/2005 |
Van Herk Groep BV
 Van Herk Groep BV HomebuildingConsumer Durables Provides construction services for residential and utility buildings, healthcare & education sectors | Directeur Financier/CFO | - |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Directeur/Membre du Conseil | 01/02/2016 |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Directeur/Membre du Conseil | - |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services Develops molecular diagnostic tests for blood cancers | Directeur/Membre du Conseil | - |
Anciens postes connus de Erik Esveld
| Sociétés | Poste | Fin |
|---|---|---|
Ht Projecktentwicklung GmbH | Directeur/Membre du Conseil | - |
Campus Fraxinus Excelsior BV | Directeur/Membre du Conseil | - |
de Hoben GmbH
 de Hoben GmbH Real Estate DevelopmentFinance Engages in buying and selling of land, buildings and apartments | Directeur/Membre du Conseil | - |
Stichting Op Klompen Begonnen
 Stichting Op Klompen Begonnen Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Erik Esveld
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Nyenrode Business Universiteit
 Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioInvent International AB
 BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Van Herk Investments BV
Van Herk Investments BV Investment ManagersFinance Van Herk Investments invests in companies located in Central and Eastern Europe, India and the United States, primarily in Europe with an enterprise value ranging from EUR 10 - 150 million. The firm focuses on a broad range of sectors and industries. It provides financing for early and buyout transactions. It also makes investments public companies and venture capital funds. | Finance |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Operates gene expression analysis-based diagnostics company which development and commercialization of diagnostic tests using tumor gene expression profiling | Health Services |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Van Herk Groep BV
Van Herk Groep BV HomebuildingConsumer Durables Provides construction services for residential and utility buildings, healthcare & education sectors | Consumer Durables |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Provides genomics technologies for clinical management of cancer | Health Technology |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services Develops molecular diagnostic tests for blood cancers | Health Services |
AEC Skyline Holding BV | |
Stichting Op Klompen Begonnen
Stichting Op Klompen Begonnen Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Stichting Start2Cure
 Stichting Start2Cure Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
de Hoben GmbH
de Hoben GmbH Real Estate DevelopmentFinance Engages in buying and selling of land, buildings and apartments | Finance |
Campus Fraxinus Excelsior BV | |
Ht Projecktentwicklung GmbH |
